MMP2 and breast cancer: Considering the characteristics of breast molecular subtypes and hormone-positive BC expression of VEGF (15), research has shown that cancer progression can be arrested or slowed down by targeting TGF-β1, MMP-2, and MMP-9 when irradiated by a proton beam (7).